GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » EV-to-EBITDA

Allegra Medical Technologies (ASX:AMT) EV-to-EBITDA : -2.15 (As of May. 16, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Allegra Medical Technologies's enterprise value is A$4.77 Mil. Allegra Medical Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.22 Mil. Therefore, Allegra Medical Technologies's EV-to-EBITDA for today is -2.15.

The historical rank and industry rank for Allegra Medical Technologies's EV-to-EBITDA or its related term are showing as below:

ASX:AMT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.01   Med: -4.6   Max: 180.22
Current: -2.15

During the past 13 years, the highest EV-to-EBITDA of Allegra Medical Technologies was 180.22. The lowest was -81.01. And the median was -4.60.

ASX:AMT's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 16.1 vs ASX:AMT: -2.15

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Allegra Medical Technologies's stock price is A$0.029. Allegra Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.040. Therefore, Allegra Medical Technologies's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Allegra Medical Technologies EV-to-EBITDA Historical Data

The historical data trend for Allegra Medical Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies EV-to-EBITDA Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.62 -3.41 -8.27 -11.47 -6.71

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -11.47 - -6.71 -

Competitive Comparison of Allegra Medical Technologies's EV-to-EBITDA

For the Medical Devices subindustry, Allegra Medical Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allegra Medical Technologies's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's EV-to-EBITDA falls into.



Allegra Medical Technologies EV-to-EBITDA Calculation

Allegra Medical Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.769/-2.216
=-2.15

Allegra Medical Technologies's current Enterprise Value is A$4.77 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allegra Medical Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies  (ASX:AMT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Allegra Medical Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.029/-0.040
=At Loss

Allegra Medical Technologies's share price for today is A$0.029.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allegra Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Allegra Medical Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.